This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety and Efficacy Study of Single Weekly Bortezo...
Clinical trial

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Read time: 1 mins
Last updated:15th Mar 2010
This is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for their disease. VELCADE´┐Ż (bortezomib) for Injection is a drug under development by Millennium Pharmaceuticals, Inc.
Category Value
Study start date 2010-03-15

View full details